Pfizer CT.gov Call Center

Trials

Studies that name Pfizer CT.gov Call Center as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:24 UTC. Showing 200 of 3797. Open this list on ClinicalTrials.gov

• Ph3
  NCT07923981 · A Study to Assess the Safety of Marstacimab and How Well it Works in People With Mild to Moderate Hemophilia A or B Without Inhibitors

  Pfizer · recruiting · Hemophilia A or B · study director
• N/A
  NCT07927023 · A Study to Learn About a Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma

  Pfizer · not yet recruiting · Multiple Myeloma · study director
• Ph3
  NCT07919678 · A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)

  Pfizer · recruiting · Obesity, Overweight, Osteoarthritis of the Knee · study director
• Ph3
  NCT07915609 · A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)

  Pfizer · recruiting · Obesity, Overweight and/or Obesity, Knee Osteoarthritis · study director
• N/A
  NCT07909122 · Real-World Treatment Patterns and Effectiveness of Anti-EGFR- and Anti-VEGF-based Therapies in Left-sided RAS Wild-Type Metastatic Colorectal Cancer

  Pfizer · not yet recruiting · Metastatic Colorectal Cancer · study director
• N/A
  NCT07906262 · Efficacy of Rimegepant 75 mg for the Acute Treatment of Migraine: a Bayesian Individual Participant Data Meta-analysis Standardized to Defined Target Populations

  Pfizer · active not recruiting · Migraine · study director
• Ph1
  NCT07903415 · A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.

  Pfizer · recruiting · Pancreatic Ductal Adenocarcinoma, Esophageal Cancer, Carcinoma, Non-Small-Cell Lung (NSCLC) · study director
• N/A
  NCT07900139 · A Study to Learn About COVID-19 Antivirals in People With SARS-CoV-2 Infection From 2023-2026

  Pfizer · active not recruiting · COVID-19 SARS-CoV-2 Infection · study director
• Ph1
  NCT07897708 · A Study to Learn How Different Amounts of the Study Medicine Called PF-08161842 Are Tolerated and Act in the Body in Healthy and Older Adults

  Pfizer · not yet recruiting · Alzheimer Disease · study director
• Ph1
  NCT07897721 · A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors

  Pfizer · not yet recruiting · Advanced Breast Cancer, Advanced or Metastatic Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-) · study director
• N/A
  NCT07897669 · A Real-world Study to Learn About of the Characteristics and Outcomes of Advanced or Metastatic Bladder Cancer Patients With Different Histologies

  Pfizer · not yet recruiting · Metastatic Urothelial Carcinoma, Urothelial Cancer, Urothelial Carcinoma · study director
• Ph3
  NCT07890597 · A Study of a Medicine Called Atirmociclib in Combination With Giredestrant in Adult Participants With ER-positive, HER2-negative Early-stage Breast Cancer

  Pfizer · not yet recruiting · Early Breast Cancer, Estrogen Receptor Positive (ER+), Human Epidermal Growth Factor Receptor 2 Negative (HER2-) · study director
• Ph3
  NCT07885956 · A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Older Adults

  Pfizer · not yet recruiting · Respiratory Syncytial Virus (RSV) · study director
• N/A
  NCT07887867 · A Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermatitis Who Have Switched From Other Therapies

  Pfizer · not yet recruiting · Dermatitis, Atopic · study director
• Ph3
  NCT07881757 · A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)

  Pfizer · recruiting · Apnea, Sleep Disorders, Overweight and/or Obesity · study director
• Ph4
  NCT07881835 · A Phase IV Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma That is Not Responding to Four or More Standard Treatments or Has Come Back After Several Standard Treatments

  Pfizer · not yet recruiting · Relapsed/Refractory Multiple Myeloma, Multiple Myeloma · study director
• Ph3
  NCT07874633 · A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or Obesity

  Pfizer · recruiting · Obesity, Overweight · study director
• Ph1
  NCT07876518 · A Study to Learn How Different Amounts of the Study Medicine Called PF-08656795 Are Tolerated and Act in Adults With Overweight or Obesity

  Pfizer · not yet recruiting · Overweight and/or Obesity · study director
• Ph1
  NCT07876531 · A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or Obesity

  Pfizer · recruiting · Overweight and/or Obesity, Healthy Participants · study director
• Ph3
  NCT07869043 · A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe Asthma

  Pfizer · recruiting · Asthma · study director
• N/A
  NCT07859527 · A Study to Learn About the Study Medicine (Called Marstacimab) in People With Hemophilia A or B

  Pfizer · not yet recruiting · Hemophilia · study director
• Ph3
  NCT07845500 · A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity

  Pfizer · recruiting · Obesity, Overweight and/or Obesity, Overweight · study director
• Ph1
  NCT07845513 · A Study to Learn About the Study Medicine Called PF-08653944 in Otherwise Healthy Chinese Adults With Overweight or Obesity

  Pfizer · active not recruiting · Overweight, Obesity, Healthy Adults · study director
• Ph3
  NCT07839884 · A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of Time

  Pfizer · not yet recruiting · Moderate to Severe Chronic Obstructive Pulmonary Disease · study director
• Ph3
  NCT07839871 · Study to Learn About a Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV Disease

  Pfizer · recruiting · Respiratory Syncytial Virus (RSV) · study director
• Ph3
  NCT07823608 · A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)

  Pfizer · recruiting · Apnea, Sleep Disorders, Overweight and/or Obesity · study director
• Ph3
  NCT07823595 · Abrocitinib Treatment of Atopic Dermatitis in Children 2 to Less Than 6 Years of Age

  Pfizer · not yet recruiting · Atopic Dermatitis · study director
• N/A
  NCT07821216 · Real-World Effectiveness of Ritlecitinib in Alopecia Areata Patients in the US: A Retrospective Analysis Using EHR and Claims Data

  Pfizer · active not recruiting · Alopecia Areata · study director
• Ph3
  NCT07819097 · A Study to Learn About the Safety and Immune Responses of RSVpreF in Older Adults

  Pfizer · recruiting · Adult, Healthy Participants · study director
• Ph3
  NCT07798648 · A Study of COVID-19 Vaccine(s) in Children and Adults

  BioNTech SE · recruiting · COVID-19 Vaccines · study director
• Ph3
  NCT07794774 · A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)

  Pfizer · recruiting · Obesity · study director
• Ph3
  NCT07794748 · A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults

  Pfizer · recruiting · Pneumococcal Disease · study director
• Ph3
  NCT07794761 · A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)

  Pfizer · recruiting · Obesity · study director
• Ph1
  NCT07792941 · A Study to Learn About the Single Dose Pharmacokinetics of Study Medicine Called Tilrekimig in Healthy Adults When Co-Mixed With rHuPH20

  Pfizer · active not recruiting · Healthy · study director
• Ph3
  NCT07792954 · A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity

  Pfizer · recruiting · Obesity, Overweight · study director
• Ph3
  NCT07783425 · A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

  Pfizer · recruiting · Atopic Dermatitis · study director
• Ph1/Ph2
  NCT07782450 · A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases

  Pfizer · not yet recruiting · Systemic Lupus Erythematosus, Rheumatoid Arthritis, Idiopathic Inflammatory Myositis · study director
• N/A
  NCT07779590 · A Study to Learn About the Outcomes Between Study Medicines, Enzalutamide and Darolutamide Among Men With Metastatic Castration Sensitive Prostate Cancer (mCSPC)

  Pfizer · active not recruiting · Metastatic Castration Sensitive Prostate Cancer (mCSPC) · study director
• Ph3
  NCT07772921 · A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma

  Pfizer · recruiting · Asthma · study director
• Ph3
  NCT07768345 · A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults

  Pfizer · recruiting · Respiratory Syncytial Virus (RSV) · study director
• N/A
  NCT07768163 · A Study to Learn About the Safety of PENBRAYA During Pregnancy

  Pfizer · recruiting · Meningococcal Disease · study director
• Ph4
  NCT07768358 · Tucatinib Continuation Study

  Pfizer · not yet recruiting · HER2-positive Breast Cancer, Cervical Cancer, Biliary Tract Neoplasms · study director
• Ph3
  NCT07765888 · A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

  Pfizer · recruiting · Atopic Dermatitis · study director
• Ph3
  NCT07754539 · A Study to Evaluate 20vPnC in Healthy Chinese Infants

  Pfizer · recruiting · Pneumococcal Diseases · study director
• Ph3
  NCT07733765 · A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata

  Pfizer · recruiting · Alopecia Areata · study director
• Ph4
  NCT07730450 · A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age

  BioNTech SE · recruiting · COVID-19 Vaccines · study director
• Ph1
  NCT07731139 · A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity

  Pfizer · recruiting · Obesity · study director
• Ph1
  NCT07731100 · A Study to Learn About How Food Affects the Uptake of Study Medicine Prifetrastat Into the Blood in Healthy Adults

  Pfizer · not yet recruiting · Healthy Adults · study director
• Ph3
  NCT07729462 · A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine

  Pfizer · recruiting · Preventive Treatment of Migraine · study director
• Ph1
  NCT07725809 · A Study to Learn How the Study Medicine Called PF-08653945 is Taken up Into the Blood in Adults With Overweight or Obesity

  Pfizer · active not recruiting · Overweight, Obesity, Healthy · study director
• Ph1
  NCT07721402 · A Study to Learn About How Different Forms of Study Medicine Prifetrastat Are Taken Up Into the Blood in Healthy Adults

  Pfizer · recruiting · Healthy Participant · study director
• Ph4
  NCT07685769 · A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India

  Pfizer · recruiting · Acute Treatment of Migraine · study director
• Ph1
  NCT07677358 · A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in People With Normal Liver Function and Different Levels of Liver Disease

  Pfizer · recruiting · Hepatic Impairment, Healthy, Hepatic Insufficiency, Healthy Adults · study director
• N/A
  NCT07673081 · Real-World Effectiveness of RSV Vaccines Among Adults Using Target Trial Emulation in Epic Cosmos

  Pfizer · active not recruiting · Respiratory Syncytial Virus (RSV) · study director
• Ph1
  NCT07663630 · A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight Loss

  Pfizer · not yet recruiting · Non-small Cell Lung Cancer (NSCLC), Cachexia · study director
• Ph3
  NCT07660198 · Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents

  Pfizer · recruiting · Pneumococcal Disease · study director
• Ph1
  NCT07660731 · A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma

  Pfizer · recruiting · Healthy Volunteer Study, Healthy Adults, Healthy Participants · study director
• Ph3
  NCT07653100 · A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreF

  Pfizer · recruiting · Respiratory Syncytial Virus (RSV) · study director
• Ph1
  NCT07636018 · A Study to Learn if the Study Medicine Called Fluconazole Changes How the Other Body Processes the Study Medicine PF-07248144

  Pfizer · completed · Healthy Adults · study director
• Ph3
  NCT07629440 · A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.

  Pfizer · recruiting · Pneumococcal Disease · study director
• Ph4
  NCT07609914 · A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine

  Pfizer · recruiting · Acute Treatment of Migraine · study director
• Ph1
  NCT07597928 · A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults

  Pfizer · completed · Healthy Adults, Healthy · study director
• Ph3
  NCT07595549 · A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  Pfizer · recruiting · Obesity, Overweight and/or Obesity, Overweight · study director
• Ph1
  NCT07594769 · A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults

  Pfizer · completed · Migraine · study director
• Ph1
  NCT07587697 · A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fasting Conditions

  Pfizer · completed · Healthy Adults · study director
• Ph1
  NCT07578636 · A Study to Understand What the Body Does to the Study Medicine Called PF-07799544 When Taken by Healthy Adults

  Pfizer · completed · Healthy Male Volunteers · study director
• Ph3
  NCT07578649 · Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer

  Pfizer · recruiting · Endometrial Neoplasms, Endometrial Cancer · study director
• Ph2
  NCT07575932 · A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity

  Pfizer · active not recruiting · Overweight, Obesity, Overweight and/or Obesity · study director
• Ph1
  NCT07575945 · A Study to Learn if a Medicine Called Itraconazole Changes How the Body Processes the Study Medicine PF-08642534 in Healthy Adults.

  Pfizer · completed · Healthy Participant · study director
• Ph1
  NCT07575906 · A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is Tolerated in the Body of Healthy Adults.

  Pfizer · completed · Healthy · study director
• Ph3
  NCT07573462 · A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants

  Pfizer · recruiting · Pneumococcal Disease · study director
• N/A
  NCT07567352 · A Study to Learn About Patients With Non-Small Cell Lung Cancer (NSCLC) Who Took Lorlatinib as Their First Treatment

  Pfizer · active not recruiting · Non-Small-Cell Lung, ALK-positive Advanced NSCLC, ALK-positive Non-small-cell Lung Cancer · study director
• Ph1
  NCT07563894 · Relative Bioavailability and Impact of Rabeprazole for PF-07799933, Food-Effect for PF-07799933 and PF-07799544

  Pfizer · completed · Healthy · study director
• N/A
  NCT07556549 · A Study to Learn About Study Medicine Lorlatinib, as a First-line Treatment in Chinese Adults With ALK-positive a/mNSCLC

  Pfizer · completed · Non-Small Cell Lung Cancer ALK-positive · study director
• Ph1
  NCT07552779 · A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir

  Pfizer · completed · Coronavirus Disease 2019, Coronavirus Disease 2019 (COVID-19), COVID-19 (Coronavirus Disease 2019) · study director
• Ph3
  NCT07543380 · A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.

  Pfizer · completed · Respiratory Syncytial Virus (RSV) · study director
• Ph1
  NCT07542886 · A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin (Somatropin) Delivery and Taken up Into the Blood in Healthy Adults

  Pfizer · completed · Healthy · study director
• N/A
  NCT07527832 · An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan.

  Pfizer · completed · Colorectal Cancer · study director
• Ph1
  NCT07519135 · A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function

  Pfizer · recruiting · Healthy · study director
• Ph1
  NCT07519655 · Phase 1 Study of PF-08046033 in Advanced Solid Tumors

  Pfizer · recruiting · Non-Small-Cell Lung, Esophageal Cancer, Cutaneous Melanoma · study director
• Ph1
  NCT07514156 · A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 Are Tolerated and Act in the Body in Healthy Adults.

  Pfizer · completed · Healthy Adults · study director
• Ph1
  NCT07508241 · A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity

  Pfizer · active not recruiting · Obesity, Overweight and/or Obesity, Overweight · study director
• Ph1
  NCT07508228 · A Study to Understand How a Study Medicine Called PF-07328948 is Absorbed and Processed in the Body of Healthy Male Adults

  Pfizer · completed · Healthy · study director
• Ph3
  NCT07500506 · A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine

  Pfizer · recruiting · Lyme Disease · study director
• N/A
  NCT07494656 · A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in Germany

  Pfizer · active not recruiting · ATTR-CM (Transthyretin Amyloid Cardiomyopathy) · study director
• N/A
  NCT07497854 · A Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea

  Pfizer · not yet recruiting · Migraine With or Without Aura · study director
• Ph2
  NCT07489066 · Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

  Pfizer · recruiting · Carcinoma, Non-Small-Cell Lung, Lung Cancer (NSCLC) · study director
• Ph2
  NCT07476287 · Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

  Pfizer · recruiting · Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), Transformed Small Cell Lung Cancer · study director
• Ph2
  NCT07470879 · A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

  Pfizer · recruiting · Colitis, Ulcerative · study director
• Ph1
  NCT07470866 · A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions

  Pfizer · terminated · Healthy · study director
• N/A
  NCT07459686 · An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis

  Pfizer · active not recruiting · Ulcerative Colitis (UC) · study director
• Ph1
  NCT07455240 · A Study to Learn About How the Body Processes the Study Medicine Called PF-07328948 in Healthy Chinese Adults

  Pfizer · completed · Healthy Participant · study director
• Ph2
  NCT07431853 · A Study to Learn About mRNA Vaccines Against Influenza in Adults

  Pfizer · recruiting · Healthy Adults · study director
• Ph1
  NCT07426757 · An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

  Pfizer · recruiting · Advanced Malignancies, Advanced Cancer · study director
• Ph1
  NCT07423286 · A Study to Understand What the Body Does to the Study Medicine Called PF-07248144 When Taken by Healthy Adults

  Pfizer · completed · Healthy Adult Participants · study director
• Ph1/Ph2
  NCT07421700 · Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

  Pfizer · recruiting · Urothelial Cancer, Advanced/Metastatic Urothelial Cancer, Urothelial Carcinoma · study director
• Ph1
  NCT07400679 · A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity

  Pfizer · completed · Overweight, Obesity, Healthy · study director
• Ph3
  NCT07400653 · A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

  Pfizer · active not recruiting · Obesity, Overweight and/or Obesity, Overweight · study director
• Ph2/Ph3
  NCT07392892 · Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

  Pfizer · recruiting · Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma, Metastatic Gastric Cancer, Gastroesophageal Junction Cancer · study director
• N/A
  NCT07391761 · A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan

  Pfizer · active not recruiting · Refractory Multiple Myeloma (RRMM) · study director
• N/A
  NCT07386847 · A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer

  Pfizer · completed · Metastatic Urothelial Carcinoma, Urothelial Cancer, Urothelial Carcinoma · study director
• Ph2/Ph3
  NCT07363694 · A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  Pfizer · recruiting · Moderate to Severe Chronic Obstructive Pulmonary Disease · study director
• Ph1
  NCT07335419 · A Study to Learn if Itraconazole Changes How the Body Processes PF-07248144 (Study Medicine)

  Pfizer · completed · Healthy Adult Participants · study director
• Ph1
  NCT07318805 · A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

  Pfizer · recruiting · Advanced Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-), Colorectal Cancer · study director
• Ph1
  NCT07315360 · A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function

  Pfizer · recruiting · Renal Impairment, Healthy · study director
• Ph3
  NCT07311850 · Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity

  Pfizer · active not recruiting · Obesity and Overweight · study director
• Ph3
  NCT07300839 · A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

  BioNTech SE · completed · COVID-19, SARS-COV-2 Infection · study director
• Ph1
  NCT07284173 · A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Medicine PF-08049820 in Healthy Chinese Adults.

  Pfizer · completed · Healthy Adults · study director
• Ph3
  NCT07282665 · A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

  Pfizer · recruiting · Clostridoides Difficile Associated Disease · study director
• Ph1
  NCT07269301 · A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function

  Pfizer · recruiting · Hepatic Impairment, Healthy · study director
• N/A
  NCT07261085 · A Study to Learn How Paxlovid [Nirmatrelvir-ritonavir/PF-07321332] Works in COVID-19 Patients Who Are Elderly or Have Medical Conditions.

  Pfizer · completed · COVID-19 · study director
• Ph1
  NCT07261371 · A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy Adults

  Pfizer · completed · Healthy Volunteer · study director
• N/A
  NCT07251465 · A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting Pneumonia

  Pfizer · active not recruiting · Community-Acquired Pneumonia (CAP) · study director
• N/A
  NCT07249320 · Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants

  Pfizer · active not recruiting · Respiratory Syncytial Virus (RSV) · study director
• Ph1
  NCT07235150 · A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body in Healthy Adults

  Pfizer · terminated · Healthy · study director
• Ph1
  NCT07235163 · A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 Are Tolerated and Act in the Body of Healthy Adults

  Pfizer · recruiting · Healthy · study director
• N/A
  NCT07235397 · Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset

  Pfizer · not yet recruiting · Respiratory Syncytial Virus Infections · study director
• Ph1
  NCT07235137 · A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adults

  Pfizer · completed · Healthy Participant · study director
• Ph1
  NCT07231978 · A Study to Learn How Different Forms of the Study Medicine Called Prazosin Are Taken up Into the Blood in Healthy Adults

  Pfizer · completed · Healthy · study director
• Ph1
  NCT07231991 · A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function

  Pfizer · recruiting · Healthy Participants · study director
• Ph2
  NCT07228390 · A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.

  Pfizer · active not recruiting · Hidradenitis Suppurativa · study director
• Ph3
  NCT07226882 · A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults

  Pfizer · active not recruiting · Lyme Borreliosis · study director
• Ph2/Ph3
  NCT07226999 · Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

  Pfizer · recruiting · Small Cell Lung Cancer (SCLC) · study director
• Ph1/Ph2
  NCT07227298 · Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

  Pfizer · recruiting · Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer · study director
• Ph1/Ph2
  NCT07227415 · Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

  Pfizer · recruiting · Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma, Renal Cancer · study director
• Ph1/Ph2
  NCT07227012 · Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

  Pfizer · recruiting · Carcinoma, Hepatocellular, Hepatocellular Cancer, Hepatocellular Carcinoma · study director
• N/A
  NCT07226531 · Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US

  Pfizer · completed · Alopecia Areata · study director
• Ph3
  NCT07222566 · Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  Pfizer · recruiting · Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung · study director
• Ph3
  NCT07222800 · Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  Pfizer · recruiting · Intestinal Neoplasms, Gastrointestinal Neoplasms, Digestive System Neoplasms · study director
• Ph3
  NCT07222384 · A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19

  BioNTech SE · completed · COVID-19, SARS-COV-2 Infection · study director
• Ph2
  NCT07219615 · A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.

  Pfizer · recruiting · Chronic Spontaneous Urticaria · study director
• Ph2
  NCT07216027 · A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

  Pfizer · recruiting · Atopic Dermatitis, Eczema, Atopic · study director
• Ph1
  NCT07215078 · Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants

  Pfizer · completed · Healthy Volunteer · study director
• Ph1
  NCT07206225 · A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

  Pfizer · recruiting · Non-muscle Invasive Bladder Cancer · study director
• Ph1
  NCT07198035 · A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144

  Pfizer · completed · Healthy Adults · study director
• N/A
  NCT07200128 · A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings

  Pfizer · completed · Severe Alopecia Areata · study director
• Ph1
  NCT07190430 · A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants

  Pfizer · completed · Atopic Dermatitis · study director
• N/A
  NCT07177209 · Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population

  Pfizer · completed · Ulcerative Colitis · study director
• Ph1
  NCT07172321 · A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults

  Pfizer · completed · Atopic Dermatitis · study director
• N/A
  NCT07161687 · A Study to Learn About the Study Medicine -Hympavzi in Congenital Hemophilia Patients Without Inhibitors in Japan.

  Pfizer · active not recruiting · Hemophilia A or B · study director
• Ph1
  NCT07160738 · A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060

  Pfizer · completed · Healthy Adults · study director
• Ph3
  NCT07160244 · BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

  Pfizer · recruiting · Healthy · study director
• Ph1
  NCT07153159 · A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women

  Pfizer · completed · Healthy Participant · study director
• N/A
  NCT07152119 · A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.

  Pfizer · recruiting · Severe Alopecia Areata · study director
• Ph3
  NCT07144280 · A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

  Pfizer · recruiting · Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma · study director
• Ph1
  NCT07130097 · A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants

  Pfizer · completed · Healthy Participant · study director
• Ph1
  NCT07127770 · A Study to Understand How the Body Processes [14C]PF-07104091 in Healthy Participants

  Pfizer · completed · Healthy Adults · study director
• Ph1
  NCT07122986 · A Study to Learn About a Vaccine Against E Coli in Healthy Adults

  Pfizer · active not recruiting · Healthy Participants · study director
• N/A
  NCT07122661 · STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)

  Pfizer · active not recruiting · Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus, Lower Respiratory Tract Disease · study director
• Ph1
  NCT07117799 · A Study to Learn About How Different Forms of Study Medicine PF-07248144 Are Taken Up Into the Blood in Healthy Adults

  Pfizer · completed · Healthy Adults · study director
• N/A
  NCT07096024 · A Study to Understand About the Study Medicine Palbociclib in Breast Cancer Patients After it is Out in the Japanese Market

  Pfizer · completed · Breast Neoplasms · study director
• Ph1
  NCT07090499 · A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

  Pfizer · recruiting · Advanced/Metastatic Solid Tumors, Bladder Cancer, Urothelial Carcinoma · study director
• N/A
  NCT07090486 · A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions.

  Pfizer · completed · COVID-19 · study director
• N/A
  NCT07089680 · A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19

  Pfizer · completed · Coronavirus Disease 2019 (COVID-19) · study director
• N/A
  NCT07086651 · A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)

  Pfizer · completed · Metastatic Castration Sensitive Prostate Cancer (mCSPC), Cancer of the Prostate, Prostate Neoplasms · study director
• Ph1
  NCT07086677 · A Study to Learn About How a New Pneumococcal Vaccine Works in Adults

  Pfizer · active not recruiting · Streptococcus Pneumoniae · study director
• Ph1
  NCT07086664 · A Study to Learn About the Study Medicine Called PF-07258669 in Older Adults Including Those at Risk of Malnutrition

  Pfizer · terminated · Healthy Volunteers · study director
• Ph2
  NCT07073820 · A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

  Pfizer · terminated · Pulmonary Hypertension · study director
• N/A
  NCT07072793 · A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe

  Pfizer · completed · COVID-19 (Coronavirus Disease 2019) · study director
• Ph3
  NCT07069309 · A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years

  BioNTech SE · completed · COVID-19, SARS-COV-2 Infection · study director
• Ph3
  NCT07062965 · A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

  Pfizer · recruiting · Breast Cancer · study director
• Ph3
  NCT07029711 · A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

  Pfizer · active not recruiting · Severe Alopecia Areata · study director
• Ph3
  NCT07029828 · A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

  Pfizer · recruiting · Severe Alopecia Areata · study director
• Ph3
  NCT07028853 · This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  Pfizer · recruiting · Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer · study director
• Ph1
  NCT07023081 · A Study to Understand the Safety of the 20vPnC Vaccine in Healthy Chinese Adults, Children, and Infant

  Pfizer · active not recruiting · Pneumococcal Disease · study director
• Ph1
  NCT07022977 · A Study of MET233 in Individuals With Obesity or Overweight

  Pfizer · completed · Obesity and Overweight · study director
• Ph1
  NCT07019909 · A Study to Learn About How Safe and Effective is 20vPnC and 13vPnC Vaccines in Chinese Adults

  Pfizer · completed · Pneumococcal Disease · study director
• Ph1
  NCT07015918 · A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men

  Pfizer · completed · Healthy Male Volunteers · study director
• Ph3
  NCT07013474 · A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

  Pfizer · recruiting · COVID-19 Infection · study director
• Ph1
  NCT07009353 · A Study to Learn How the Study Medicine Called [14C]PF-07054894 is Processed by the Body

  Pfizer · completed · Healthy · study director
• Ph1
  NCT06994897 · A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults

  Pfizer · active not recruiting · Healthy · study director
• Ph1
  NCT06995729 · A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

  Pfizer · recruiting · Acute Treatment of Migraine · study director
• Ph2
  NCT06991257 · A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

  Pfizer · recruiting · Heart Failure · study director
• Ph2/Ph3
  NCT06989437 · A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  Pfizer · recruiting · Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma · study director
• Ph2
  NCT06977581 · A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  Pfizer · recruiting · Asthma · study director
• Ph1
  NCT06974734 · A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies

  Pfizer · terminated · Carcinoma, Non Small Cell Lung, Carcinoma, Pancreatic Ductal, Malignant Melanoma · study director
• Ph2
  NCT06973720 · A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight

  Pfizer · completed · Obesity, Overweight or Obesity · study director
• Ph1/Ph2
  NCT06966453 · A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

  Pfizer · active not recruiting · Breast Cancer, Breast Neoplasms · study director
• Ph1
  NCT06965465 · A Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 Are Tolerated and Act in the Body in Healthy Adults

  Pfizer · completed · Healthy · study director
• N/A
  NCT06962969 · A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world Database

  Pfizer · completed · Advanced or Metastatic Breast Cancer · study director
• N/A
  NCT06961331 · Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer.

  Pfizer · completed · Metastatic HER2+ Advanced Breast Cancer · study director
• Ph4
  NCT06952660 · Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

  Pfizer · recruiting · Cervical Cancer · study director
• Ph1/Ph2
  NCT06924320 · A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes

  Pfizer · completed · Obesity and Obesity-related Medical Conditions · study director
• N/A
  NCT06923137 · A Study to Learn About How Well Yearly Updates to the COVID-19 Vaccine Work to Protect People From COVID-19 and How Much Money People Spend on Healthcare for COVID-19

  Pfizer · active not recruiting · COVID-19 SARS-CoV-2 Infection, COVID-19, COVID-19 Infection · study director
• Ph1
  NCT06920498 · A Study to Learn How Different Amounts of the Study Medicine Called PF-07941944 Are Tolerated in the Body of Healthy Adults.

  Pfizer · completed · Healthy Participants · study director
• Ph1
  NCT06910839 · Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and if Either of Them Change How the Body Processes the Other Medicine in Otherwise Healthy Adults With Overweight or Obesity

  Pfizer · terminated · Overweight, Obesity · study director
• Ph1
  NCT06911788 · A Study to Learn How a Tablet Compared With an IV Infusion of the Study Medicine Called Vepdegestrant is Taken up Into the Blood in Healthy Adults

  Pfizer · completed · Healthy Participants · study director
• Ph1
  NCT06897683 · A Study to Learn if the Study Medicine Called Carbamazepine Changes How the Body Processes PF-07220060

  Pfizer · completed · Healthy Adults · study director
• N/A
  NCT06898047 · Consistency of Response With Rimegepant in Acute Treatment of Migraine

  Pfizer · active not recruiting · Migraine · study director
• N/A
  NCT06899204 · Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

  Pfizer · recruiting · Atopic Dermatitis, Atopic Dermatitis, Unspecified, Dermatitis, Atopic · study director
• Ph2
  NCT06897202 · A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

  Pfizer · completed · Obesity in Diabetes, Type 2 Diabetes Mellitus (T2DM) · study director
• Ph3
  NCT06890416 · A Study to Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in Adults

  Pfizer · completed · Respiratory Syncytial Virus (RSV) · study director
• Ph3
  NCT06873945 · A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

  Pfizer · recruiting · Alopecia Areata · study director
• N/A
  NCT06873191 · A Study to Learn More About Tukysa Once it is Out in the Korean Market

  Pfizer · not yet recruiting · HER2-positive Locally Advanced Unresectable, Metastatic Breast Cancer · study director
• Ph1
  NCT06870487 · A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers

  Pfizer · terminated · Peripheral T Cell Lymphoma, Diffuse Large B-cell Lymphoma, Classical Hodgkin Lymphoma · study director
• Ph3
  NCT06866405 · A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose

  Pfizer · recruiting · RSV Infection · study director
• N/A
  NCT06864585 · A Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Japan

  Pfizer · active not recruiting · Infectious Diseases · study director
• Ph1
  NCT06837259 · A Study to Learn if Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy Adults

  Pfizer · completed · Healthy Adults · study director
• Ph1
  NCT06821750 · A Study to Learn How Different Amounts of the Study Medicine Called PF-07314470 Are Tolerated and Act in the Body in Healthy Adults

  Pfizer · terminated · Healthy · study director
• Ph1/Ph2
  NCT06821061 · A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

  BioNTech SE · completed · Influenza, COVID-19 (Coronavirus Disease 2019) · study director

Grants

NIH projects from RePORTER, fetched 2026-11-11 22:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.